US Patent 8178555 Apoptosis signal-regulating kinase 1 inhibitors
Patent 8178555 was granted and assigned to Takeda Pharmaceutical Company on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+129 characters)
Article
Patent abstract
The present invention relates to apoptosis signal-regulating kinase 1 (“ASK1”) inhibiting compounds of the formula
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08178555 Apoptosis signal-regulating kinase 1 inhibitors US Patent 8178555 Apoptosis signal-regulating kinase 1 inhibitors
Infobox
Patent Number
0817855500
Patent Number
817855500
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081785550
Date of Patent
May 15, 2012
0Patent Application Number
124900740
Date Filed
June 23, 2009
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081785550
Date of Patent
May 15, 2012
0Patent Application Number
124900740
Date Filed
June 23, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08178555 Apoptosis signal-regulating kinase 1 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08178555
Date of patent
May 15, 2012
Patent application number
12490074
Date Filed
June 23, 2009
Patent primary examiner
Find more entities like US Patent 8178555 Apoptosis signal-regulating kinase 1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.